Quality-Adjusted Time Without Symptoms of Disease or Toxicity (Q-TWiST) in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Comparison of Ponatinib Versus Imatinib CANCER MED-US
Characterizing the heterogeneity of Castleman disease and oligocentric subtype: Findings from the ACCELERATE registry Blood Adv
Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1-2 study Lancet Haematol
Bruton tyrosine kinase covalent inhibition shapes the immune microenvironment in chronic lymphocytic leukemia Haematologica
A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR-T cell therapy in B-cell acute lymphoblastic leukemia Blood
SECURED for Health: Scaling up privacy to enable the integration of the European health data space IEEE ACCESS
Long-term survival for myeloid neoplasms and national health expenditure: A EUROCARE-6 retrospective, population-based study Eur J Cancer